Silk Road Medical Inc. (SILK) Tops Q3 EPS by 1c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
Tweet Send to a Friend
Silk Road Medical Inc. (NASDAQ: SILK) reported Q3 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27). Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
